Literature DB >> 31330093

Management of chronic myeloid leukemia in children and adolescents: Recommendations from the Children's Oncology Group CML Working Group.

Uma Athale1, Nobuko Hijiya2, Briana C Patterson3,4, John Bergsagel4, Jeffrey R Andolina5, Henrique Bittencourt6, Kirk R Schultz7, Michael J Burke8, Michele S Redell9, E Anders Kolb10, Donna L Johnston11.   

Abstract

Chronic myeloid leukemia (CML) accounts for 2-3% of leukemias in children under 15 and 9% in adolescents aged 15-19. The diagnosis and management of CML in children, adolescents, and young adults have several differences compared to that in adults. This review outlines the diagnosis and management of the underlying disease as well as challenges that can occur when dealing with CML in this patient population.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  CML; pediatric; recommendations

Year:  2019        PMID： 31330093     DOI： 10.1002/pbc.27827

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


  9 in total

Review 1.  Tyrosine Kinase Inhibitors and Beyond for Chronic Myeloid Leukemia in Children.

Authors:  Lia N Phillips; Nobuko Hijiya
Journal:  Paediatr Drugs       Date:  2021-04-26       Impact factor: 3.022

2.  Sensorineural Hearing Loss in Juvenile CML: A Rare Case Report in Surabaya, Indonesia.

Authors:  Ihda Kartika Syamsuddin; Paulus Budiono Notopuro
Journal:  Int Med Case Rep J       Date:  2022-07-12

Review 3.  Chronic Myelogenous Leukemia in Childhood.

Authors:  Stephanie M Smith; Nobuko Hijiya; Kathleen M Sakamoto
Journal:  Curr Oncol Rep       Date:  2021-03-14       Impact factor: 5.075

Review 4.  Bcr-Abl Tyrosine Kinase Inhibitors in the Treatment of Pediatric CML.

Authors:  Francesca Carofiglio; Antonio Lopalco; Angela Lopedota; Annalisa Cutrignelli; Orazio Nicolotti; Nunzio Denora; Angela Stefanachi; Francesco Leonetti
Journal:  Int J Mol Sci       Date:  2020-06-23       Impact factor: 5.923

5.  Patterns of surveillance for late effects of BCR-ABL tyrosine kinase inhibitors in survivors of pediatric Philadelphia chromosome positive leukemias.

Authors:  Stephanie M Smith; Himalee S Sabnis; Rebecca Williamson Lewis; Karen E Effinger; John Bergsagel; Briana Patterson; Ann Mertens; Kathleen M Sakamoto; Lidia Schapira; Sharon M Castellino
Journal:  BMC Cancer       Date:  2021-04-29       Impact factor: 4.430

Review 6.  Management of Chronic Myeloid Leukemia in Children and Young Adults.

Authors:  Maegan Ford; Michael Mauro; Catherine Aftandilian; Kathleen M Sakamoto; Nobuko Hijiya
Journal:  Curr Hematol Malig Rep       Date:  2022-08-03       Impact factor: 4.213

7.  Cross-Domain Text Mining to Predict Adverse Events from Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia.

Authors:  Nidhi Mehra; Armon Varmeziar; Xinyu Chen; Olivia Kronick; Rachel Fisher; Vamsi Kota; Cassie S Mitchell
Journal:  Cancers (Basel)       Date:  2022-09-26       Impact factor: 6.575

8.  A phase 2 study of nilotinib in pediatric patients with CML: long-term update on growth retardation and safety.

Authors:  Nobuko Hijiya; Alexey Maschan; Carmelo Rizzari; Hiroyuki Shimada; Carlo Dufour; Hiroaki Goto; Hyoung Jin Kang; Terri Guinipero; Zeynep Karakas; Francisco Bautista; Stéphane Ducassou; Keon Hee Yoo; Christian Michel Zwaan; Frédéric Millot; Briana Patterson; Jill Samis; Paola Aimone; Alex Allepuz; Ksenia Titorenko; Darintr Sosothikul
Journal:  Blood Adv       Date:  2021-07-27

9.  Recurrent Gastrointestinal Hemorrhage in Children with Philadelphia-Positive B-Cell Acute Lymphoblastic Leukemia Treated with Dasatinib: Case Reports.

Authors:  Xin Liao; Yuxia Guo; Yali Shen; Jianwen Xiao
Journal:  Case Rep Hematol       Date:  2020-02-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.